VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
UGUnited-Guardian, Inc.
$7.04$32M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

UG logoUnited-Guardian, Inc.(UG)Earnings, Financials & Key Ratios

UG•NASDAQ
15.3× P/E·Price updated Jun 19, 2026
SectorConsumer DefensiveIndustryHousehold ProductsSub-IndustrySuppliers, Durables and Specialty Retailers
AboutUnited-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL NATURAL consisting of natural ingredients for cosmetic use; LUBRAJEL MARINE; LUBRASIL II SB, a special formulation of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base; LUBRAJEL II XD; B-122, a powdered lubricant that is used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; KLENSOFT, a surfactant, which is used in shampoos, shower gels, makeup removers, and other cosmetic formulations; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC and LUBRAJEL FA that are LUBRAJEL formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder, and localized infections in the peritoneum, as well as eye, ear, nose and throat, and sinuses. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and development primarily related to the development of cosmetic ingredients. It markets its products through marketing partners, distributors, and wholesalers. The company was founded in 1942 and is based in Hauppauge, New York.Show more
  • Revenue$11M-13.4%
  • EBITDA$2M-37.2%
  • Net Income$2M-35.2%
  • EPS (Diluted)0.46-35.2%
  • Gross Margin47.73%-10.0%
  • EBITDA Margin22.3%-27.4%
  • Operating Margin21.27%-28.9%
  • Net Margin19.97%-25.2%
  • ROE18.22%-34.8%

UG Key Insights

United-Guardian, Inc. (UG) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Excellent 3Y average ROE of 23.7%
  • ✓FCF machine: 18.1% free cash flow margin
  • ✓Healthy 5Y average net margin of 24.8%

✗Weaknesses

  • ✗Dividend payout exceeds 100% of earnings

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when UG posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

UG Price & Volume

United-Guardian, Inc. (UG) stock price & volume — 10-year historical chart

Loading chart...

UG Growth Metrics

United-Guardian, Inc. (UG) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-2.8%
5 Years-0.82%
3 Years-6.01%
TTM-13.43%

Profit CAGR

10 Years-7.53%
5 Years-8.62%
3 Years-6.42%
TTM-35.23%

EPS CAGR

10 Years-7.47%
5 Years-8.57%
3 Years-6.35%
TTM-35.21%

Return on Capital

10 Years37.2%
5 Years35.13%
3 Years26%
Last Year18.95%

UG Recent Earnings

United-Guardian, Inc. (UG) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat Revenue 2/12 qtrs (40%)
Q2 2026Latest
May 8, 2026
Metric
Actual
Est
EPS
$0.18
—
Rev
$3M
—
Q2 2026
Mar 27, 2026
Metric
Actual
Est
EPS
$0.14
—
Rev
$3M
—
Q4 2025
Nov 6, 2025
Metric
Actual
Est
EPS
$0.06
—
Rev
$2M
—
Q3 2025
Aug 8, 2025
Metric
Actual
Est
EPS
$0.14
—
Rev
$3M
—
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 8, 2026
$0.18
$3M
Q2 2026Mar 27, 2026
$0.14
$3M
Q4 2025Nov 6, 2025
$0.06
$2M
Q3 2025Aug 8, 2025
$0.14
$3M
Based on last 12 quarters of dataView full earnings history →

UG Peer Comparison

United-Guardian, Inc. (UG) competitors in Suppliers, Durables and Specialty Retailers — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
IOSP logoIOSPInnospec Inc.Direct Competitor2.04B82.7317.72-3.65%6.38%8.64%0.07
KRMD logoKRMDKORU Medical Systems, Inc.Direct Competitor179.14M3.90-68.3022.23%-5.27%-13.61%0.21
LIQT logoLIQTLiqTech International, Inc.Direct Competitor8.95M0.90-1.0113.03%-55.45%-79.65%1.67
CODA logoCODACoda Octopus Group, Inc.Direct Competitor112.81M10.0027.0330.75%17.66%8.33%0.01
CBT logoCBTCabot CorporationProduct Competitor4.79B91.8015.25-7.04%7.97%16.75%0.71
BCPC logoBCPCBalchem CorporationProduct Competitor5.31B165.9234.938.75%14.95%12.38%0.15
HWKN logoHWKNHawkins, Inc.Product Competitor3.37B161.4541.2911.21%7.52%15.96%0.49
ASIX logoASIXAdvanSix Inc.Product Competitor535.41M19.8611.030.31%0.67%1.28%0.47

Compare UG vs Peers

United-Guardian, Inc. (UG) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs IOSP

Most directly comparable listed peer for UG.

Scale Benchmark

vs ECL

Larger-name benchmark to compare UG against a more recognizable public peer.

Peer Set

Compare Top 5

vs IOSP, KRMD, LIQT, CODA

UG Income Statement

United-Guardian, Inc. (UG) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Sales/Revenue
12.97M13.77M13.6M10.99M13.93M12.7M10.89M12.18M10.55M
Revenue Growth %
20.33%6.18%-1.24%-19.21%26.79%-8.84%-14.28%11.91%-13.43%
Cost of Goods Sold
5.3M5.67M5.66M4.87M5.75M6M5.48M5.72M5.51M
COGS % of Revenue
40.88%41.16%41.6%44.35%41.26%47.22%50.34%46.97%52.27%
Gross Profit
7.67M▲ 0%
8.1M▲ 5.7%
7.94M▼ 2.0%
6.11M▼ 23.0%
8.18M▲ 33.8%
6.7M▼ 18.1%
5.41M▼ 19.3%
6.46M▲ 19.5%
5.03M▼ 22.1%
Gross Margin %
59.12%58.84%58.4%55.65%58.74%52.78%49.66%53.03%47.73%
Gross Profit Growth %
30.07%5.68%-1.98%-23.02%33.82%-18.08%-19.35%19.51%-22.1%
Operating Expenses
2.43M2.52M2.55M2.48M2.51M2.66M2.54M2.81M2.79M
OpEx % of Revenue
18.75%18.32%18.72%22.55%18.05%20.99%23.36%23.1%26.45%
Selling, General & Admin
1.79M2.12M0000000
SG&A % of Revenue
13.77%15.42%-------
Research & Development
646.08K399.52K397.39K451.21K478.64K490.77K463.99K456.78K463.64K
R&D % of Revenue
4.98%2.9%2.92%4.11%3.44%3.86%4.26%3.75%4.4%
Other Operating Expenses
002.15M2.03M2.04M2.17M2.08M2.36M2.33M
Operating Income
5.24M▲ 0%
5.58M▲ 6.6%
5.4M▼ 3.3%
3.64M▼ 32.6%
5.67M▲ 55.9%
4.04M▼ 28.8%
2.86M▼ 29.1%
3.65M▲ 27.4%
2.24M▼ 38.5%
Operating Margin %
40.37%40.52%39.68%33.1%40.68%31.79%26.3%29.94%21.27%
Operating Income Growth %
54.46%6.57%-3.3%-32.61%55.85%-28.76%-29.08%27.38%-38.48%
EBITDA
5.44M5.77M5.57M3.8M5.81M4.17M2.97M3.74M2.35M
EBITDA Margin %
41.92%41.92%40.97%34.6%41.73%32.86%27.27%30.72%22.3%
EBITDA Growth %
52%6.17%-3.47%-31.77%52.92%-28.22%-28.85%26.07%-37.17%
D&A (Non-Cash Add-back)
200.68K191.94K175.81K165.26K145.98K135.4K105.68K95.89K108.2K
EBIT
5.24M5.58M5.4M3.64M5.67M4.04M2.86M3.65M2.24M
Net Interest Income
00203.33K226.25K233.86K-1.38M306.65K434.68K365.31K
Interest Income
00203.33K226.25K233.86K236.69K306.65K434.68K365.31K
Interest Expense
0227.98K-001.62M000
Other Income/Expense
315.17K-113.99K634.4K524.83K210.84K-809.55K387.75K461.67K399.67K
Pretax Income
5.55M▲ 0%
5.47M▼ 1.5%
6.03M▲ 10.3%
4.16M▼ 31.0%
5.88M▲ 41.3%
3.23M▼ 45.1%
3.25M▲ 0.7%
4.11M▲ 26.4%
2.64M▼ 35.7%
Pretax Margin %
42.8%39.7%44.34%37.88%42.2%25.42%29.86%33.73%25.06%
Income Tax
1.71M1.11M1.27M856.02K1.22M658.17K669.41K857.58K537.28K
Effective Tax Rate %
30.74%20.37%21.04%20.57%20.75%20.39%20.59%20.87%20.33%
Net Income
3.84M▲ 0%
4.35M▲ 13.2%
4.76M▲ 9.4%
3.3M▼ 30.6%
4.66M▲ 41.0%
2.57M▼ 44.8%
2.58M▲ 0.5%
3.25M▲ 25.9%
2.11M▼ 35.2%
Net Margin %
29.64%31.61%35.01%30.08%33.44%20.23%23.71%26.69%19.97%
Net Income Growth %
48.94%13.22%9.41%-30.59%40.96%-44.84%0.46%25.94%-35.23%
Net Income (Continuing)
3.84M4.35M4.76M3.3M4.66M2.57M2.58M3.25M2.11M
Discontinued Operations
000000000
Minority Interest
000000000
EPS (Diluted)
0.84▲ 0%
0.95▲ 13.1%
1.04▲ 9.5%
0.72▼ 30.8%
1.01▲ 40.3%
0.56▼ 44.6%
0.56▲ 0.0%
0.71▲ 26.8%
0.46▼ 35.2%
EPS Growth %
50%13.1%9.47%-30.77%40.28%-44.55%0%26.79%-35.21%
EPS (Basic)
0.840.951.040.721.010.560.560.710.46
Diluted Shares Outstanding
4.59M4.58M4.59M4.59M4.59M4.59M4.59M4.59M4.59M
Basic Shares Outstanding
4.59M4.58M4.59M4.59M4.59M4.59M4.59M4.59M4.59M
Dividend Payout Ratio
169.27%110.66%106.05%108.39%111.41%121.56%17.8%84.79%131.39%

UG Balance Sheet

United-Guardian, Inc. (UG) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Total Current Assets
11.85M11.69M11.57M11.25M11.58M9.97M12.25M12.67M12.2M
Cash & Short-Term Investments
8.45M8.17M7.92M8.18M8.17M6.48M9.09M9.4M8.57M
Cash Only
724.72K550.13K1.05M591.44K531.21K830.45K8.24M1.88M1.25M
Short-Term Investments
7.72M7.62M6.87M7.59M7.64M5.65M851.32K7.52M7.32M
Accounts Receivable
1.91M1.67M2.1M1.39M1.81M1.43M1.57M1.43M1.59M
Days Sales Outstanding
53.6344.3456.3246.147.5241.0352.5442.854.93
Inventory
1.34M1.48M1.22M1.42M1.41M1.67M1.22M1.45M1.51M
Days Inventory Outstanding
92.395.4678.54106.0689.59101.7881.592.6399.83
Other Current Assets
157.96K159.36K170.47K161.21K0201.85K191.71K207.8K207.84K
Total Non-Current Assets
1M857.57K795.53K673.66K658.86K669.71K670.13K1.13M1.26M
Property, Plant & Equipment
942.89K827.92K780.71K673.66K658.86K559.16K619.2K956.39K907.18K
Fixed Asset Turnover
13.75x16.63x17.42x16.31x21.14x22.71x17.58x12.74x11.62x
Goodwill
000000000
Intangible Assets
0014.82K000000
Long-Term Investments
00-401.68K000000
Other Non-Current Assets
-111.7K-223.94K14.82K-151.68K-83.22K0000
Total Assets
12.85M▲ 0%
12.54M▼ 2.4%
12.36M▼ 1.4%
11.92M▼ 3.6%
12.24M▲ 2.7%
10.64M▼ 13.1%
12.92M▲ 21.5%
13.8M▲ 6.8%
13.46M▼ 2.4%
Asset Turnover
1.01x1.10x1.10x0.92x1.14x1.19x0.84x0.88x0.78x
Asset Growth %
-14.99%-2.4%-1.45%-3.58%2.7%-13.09%21.45%6.77%-2.42%
Total Current Liabilities
1.42M1.37M1.34M1.41M2.34M1.37M1.53M1.91M1.67M
Accounts Payable
354.29K186.8K71.39K31.8K410.89K30.41K134.45K425K480.79K
Days Payables Outstanding
24.3912.034.612.3826.091.858.9627.1131.83
Short-Term Debt
000000000
Deferred Revenue (Current)
0000190.16K015.5K012.18K
Other Current Liabilities
314.54K299.25K373.94K321.74K898.4K638.98K543.85K681.73K1.16M
Current Ratio
8.33x8.55x8.61x7.95x4.95x7.26x7.99x6.62x7.31x
Quick Ratio
7.39x7.47x7.71x6.95x4.35x6.04x7.19x5.86x6.41x
Cash Conversion Cycle
121.53127.76130.25149.78111.01140.96125.08108.32122.92
Total Non-Current Liabilities
33.85K253.58K386.86K151.68K83.22K000207.25K
Long-Term Debt
000000000
Capital Lease Obligations
000000000
Deferred Tax Liabilities
33.85K253.58K386.86K151.68K83.22K000207.25K
Other Non-Current Liabilities
000000000
Total Liabilities
1.46M1.62M1.73M1.57M2.42M1.37M1.53M1.91M2.23M
Total Debt
000000000
Net Debt
-724.72K-550.13K-1.05M-591.44K-531.21K-830.45K-8.24M-1.88M-1.25M
Debt / Equity
---------
Debt / EBITDA
---------
Net Debt / EBITDA
-0.13x-0.10x-0.19x-0.16x-0.09x-0.20x-2.78x-0.50x-0.53x
Interest Coverage
-24.48x---2.49x---
Total Equity
11.4M▲ 0%
10.92M▼ 4.1%
10.63M▼ 2.7%
10.35M▼ 2.6%
9.82M▼ 5.1%
9.27M▼ 5.6%
11.39M▲ 22.9%
11.88M▲ 4.3%
11.23M▼ 5.5%
Equity Growth %
-17.54%-4.14%-2.67%-2.62%-5.15%-5.65%22.9%4.34%-5.48%
Book Value per Share
2.482.382.312.252.142.022.482.592.44
Total Shareholders' Equity
11.4M10.92M10.63M10.35M9.82M9.27M11.39M11.88M11.23M
Common Stock
459.43K459.43K459.43K459.43K459.43K459.43K459.43K459.43K459.43K
Retained Earnings
10.47M10.47M10.17M9.89M9.36M8.81M10.93M11.42M10.77M
Treasury Stock
000000000
Accumulated OCI
466.02K00000000
Minority Interest
000000000

UG Cash Flow Statement

United-Guardian, Inc. (UG) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Cash from Operations
3.99M4.95M4.48M3.59M5.31M2.53M3.14M3.47M1.97M
Operating CF Margin %
30.79%35.95%32.91%32.72%38.14%19.89%28.89%28.45%18.65%
Operating CF Growth %
74.3%24%-9.58%-19.7%47.83%-52.47%24.53%10.23%-43.26%
Net Income
3.84M4.35M4.76M3.3M4.66M2.57M2.58M3.25M2.11M
Depreciation & Amortization
200.68K191.94K175.81K165.26K145.98K135.4K105.68K95.89K108.2K
Stock-Based Compensation
000000000
Deferred Taxes
-31.76K219.73K133.27K-235.17K-68.46K-193.77K59.61K-124.47K382.64K
Other Non-Cash Items
-29.02K341.65K-411.79K-305.75K14.45K1.08M-111.49K-43.53K-32.32K
Working Capital Changes
8.1K-155.24K-182.89K664.92K562.77K-1.06M509.3K287.49K-597.44K
Change in Receivables
-311.69K237.17K-430.13K717.87K-431.88K385.96K-135.87K140.71K-161.26K
Change in Inventory
-84.71K-141.63K249.87K-198.5K4.98K-290.22K465.51K-214.28K-54.98K
Change in Payables
271.46K-167.49K-115.41K-39.59K379.09K-380.48K104.03K290.55K55.79K
Cash from Investing
2.82M-308.76K1.07M-468.68K-183.47K897.56K4.73M-7.08M175.34K
Capital Expenditures
-38.15K-74.99K-113.77K-43.4K-116.38K-75.18K-165.72K-433.08K-58.99K
CapEx % of Revenue
0.29%0.54%0.84%0.4%0.84%0.59%1.52%3.56%0.56%
Acquisitions
4.85K70.79K113.77K43.4K116.38K37.04K000
Investments
---------
Other Investing
-4.85K-70.79K-113.77K-43.4K-116.38K010K00
Cash from Financing
-6.51M-4.82M-5.05M-3.58M-5.19M-3.12M-459.39K-2.76M-2.77M
Debt Issued (Net)
000000000
Equity Issued (Net)
000000000
Dividends Paid
-6.51M-4.82M-5.05M-3.58M-5.19M-3.12M-459.39K-2.76M-2.77M
Share Repurchases
000000000
Other Financing
000000000
Net Change in Cash
300.42K▲ 0%
-174.59K▼ 158.1%
498.18K▲ 385.3%
-456.87K▼ 191.7%
-60.23K▲ 86.8%
299.24K▲ 596.8%
7.41M▲ 2377.2%
-6.37M▼ 185.9%
-624.56K▲ 90.2%
Free Cash Flow
3.95M▲ 0%
4.88M▲ 23.3%
4.36M▼ 10.5%
3.55M▼ 18.6%
5.2M▲ 46.4%
2.45M▼ 52.9%
2.98M▲ 21.6%
3.03M▲ 1.8%
1.91M▼ 37.1%
FCF Margin %
30.49%35.41%32.08%32.32%37.31%19.29%27.37%24.9%18.09%
FCF Growth %
86.19%23.3%-10.52%-18.6%46.36%-52.86%21.58%1.83%-37.1%
FCF per Share
0.861.060.950.771.130.530.650.660.42
FCF Conversion (FCF/Net Income)
1.04x1.14x0.94x1.09x1.14x0.98x1.22x1.07x0.93x
Interest Paid
000000000
Taxes Paid
1.6M1.15M1.1M1.02M1.1M1.13M600K1.05M0

UG Key Ratios

United-Guardian, Inc. (UG) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric2016201720182019202020212022202320242025
Return on Equity (ROE)
18.2%30.49%39%44.18%31.5%46.18%26.92%24.99%27.94%18.22%
Return on Invested Capital (ROIC)
18.93%32.63%39.77%40.55%28.19%44.62%34.16%37.08%41.59%16.84%
Gross Margin
54.69%59.12%58.84%58.4%55.65%58.74%52.78%49.66%53.03%47.73%
Net Margin
23.95%29.64%31.61%35.01%30.08%33.44%20.23%23.71%26.69%19.97%
Interest Coverage
--24.48x---2.49x---
FCF Conversion
0.89x1.04x1.14x0.94x1.09x1.14x0.98x1.22x1.07x0.93x
Revenue Growth
-23.06%20.33%6.18%-1.24%-19.21%26.79%-8.84%-14.28%11.91%-13.43%
Related:UG Dividend History·UG Revenue History·UG Price History·UG P/E History·UG Financial Ratios·UG Institutional Holders

UG SEC Filings & Documents

United-Guardian, Inc. (UG) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 8, 2026·SEC

Material company update

Mar 27, 2026·SEC

Material company update

Jan 29, 2026·SEC

10-K Annual Reports

4
FY 2026

Mar 27, 2026·SEC

FY 2025

Mar 21, 2025·SEC

FY 2024

Mar 22, 2024·SEC

10-Q Quarterly Reports

6
FY 2025

Nov 6, 2025·SEC

FY 2025

Aug 8, 2025·SEC

FY 2025

May 13, 2025·SEC

UG Frequently Asked Questions

United-Guardian, Inc. (UG) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

United-Guardian, Inc. (UG) reported $10.5M in revenue for fiscal year 2025. This represents a 32% increase from $8.0M in 1996.

United-Guardian, Inc. (UG) saw revenue decline by 13.4% over the past year.

Yes, United-Guardian, Inc. (UG) is profitable, generating $2.1M in net income for fiscal year 2025 (20.0% net margin).

Dividend & Returns

Yes, United-Guardian, Inc. (UG) pays a dividend with a yield of 8.55%. This makes it attractive for income-focused investors.

United-Guardian, Inc. (UG) has a return on equity (ROE) of 18.2%. This is reasonable for most industries.

United-Guardian, Inc. (UG) generated $1.9M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in UG back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →

How much would $100/month in UG be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →